SELUTION SLR Coronary Sirolimus DEB Study: First US Patient Enrolled

SELUTION SLR Coronary Sirolimus DEB Study: First US Patient Enrolled

The first US patient has been enrolled at Medstar Washington Hospital Center in the SELUTION4ISR study evaluating SELUTION SLR™ to support FDA approval. This milestone follows Investigational Device Exemption (IDE) approval in the US in October 2022. SELUTION SLR is the first sustained limus...

Latest News

Cardiology

Approvals / Clearance

Clinical Studies / Trials